AKBA
Akebia Therapeutics Inc
Price:  
1.05 
USD
Volume:  
2,012,804.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AKBA Relative Valuation

-598.1%
Upside

As of 2024-06-18, the Relative Valuation of Akebia Therapeutics Inc (AKBA) is (5.23) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.05 USD, the upside of Akebia Therapeutics Inc based on Relative Valuation is -598.1%.

The range of the Relative Valuation is (4.50) - (5.22) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 21.9x - 30.1x 28.6x
Forward P/E multiples 18.9x - 25.4x 22.4x
Fair Price (4.50) - (5.22) (5.23)
Upside -529.0% - -596.7% -598.1%
1.05 USD
Stock Price
(5.23) USD
Fair Price

AKBA Relative Valuation - Historical P/E Data

Date P/E
2024-06-18 -4.94
2024-06-17 -5.11
2024-06-14 -5.21
2024-06-13 -5.45
2024-06-12 -5.65
2024-06-11 -5.40
2024-06-10 -5.30
2024-06-07 -5.16
2024-06-06 -5.21
2024-06-05 -5.35
2024-06-04 -5.50
2024-06-03 -5.55
2024-05-31 -5.45
2024-05-30 -5.26
2024-05-29 -5.01
2024-05-28 -5.21
2024-05-24 -5.35
2024-05-23 -5.30
2024-05-22 -5.35
2024-05-21 -5.50
2024-05-20 -5.60
2024-05-17 -5.60
2024-05-16 -5.55
2024-05-15 -5.74
2024-05-14 -5.99
2024-05-13 -6.28
2024-05-10 -5.89
2024-05-09 -6.47
2024-05-08 -6.81
2024-05-07 -6.81
2024-05-06 -7.25
2024-05-03 -6.67
2024-05-02 -6.33
2024-05-01 -6.03
2024-04-30 -6.13
2024-04-29 -6.42
2024-04-26 -6.52
2024-04-25 -6.47
2024-04-24 -6.67
2024-04-23 -6.67
2024-04-22 -6.62
2024-04-19 -6.62
2024-04-18 -6.76
2024-04-17 -6.76
2024-04-16 -6.81
2024-04-15 -6.76
2024-04-12 -7.10
2024-04-11 -7.45
2024-04-10 -7.59
2024-04-09 -7.49